If they were running a tight ship, with options open to them, and not wishing to dilute existing shareholders any more than necessary, what might it look like?
"Alongside the ATM, the company continues to routinely evaluate a number of financing approaches, including equity placements and non-dilutive opportunities such as partnering and grant funding.”
"routine"
"approaches"
Now, on one hand you could say that they are trying to appear calm under pressure, but on the other you could say that they ARE calm, confident in what they have.
The new members of the SAB and the FDA appear to be comfortable with the scientific progress, so it would appear to be reasonable that the company gets approaches for financing support.
- Forums
- ASX - By Stock
- KZA
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-13
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KZA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
1CG
ONE CLICK GROUP LIMITED
Mark Waller, MD
Mark Waller
MD
Previous Video
Next Video
SPONSORED BY The Market Online